HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G J D Hengstman Selected Research

Methotrexate (Mexate)

1/2008Open-label trial of anti-TNF-alpha in dermato- and polymyositis treated concomitantly with methotrexate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


G J D Hengstman Research Topics

Disease

6Polymyositis
01/2008 - 01/2003
6Myositis (Idiopathic Inflammatory Myopathies)
01/2008 - 01/2002
5Dermatomyositis (Dermatopolymyositis)
01/2008 - 01/2003
2Inclusion Body Myositis
02/2006 - 01/2004
2Arthralgia (Joint Pain)
02/2006 - 01/2002
1Parkinsonian Disorders (Parkinsonism)
02/2009
1Cognitive Dysfunction
02/2009
1Epilepsy (Aura)
02/2009
1Deglutition Disorders (Dysphagia)
12/2006
1Muscle Weakness
12/2006
1Muscular Diseases (Myopathy)
12/2006
1Arthritis (Polyarthritis)
02/2006
1Neoplasms (Cancer)
02/2006
1Interstitial Lung Diseases (Interstitial Lung Disease)
02/2006
1Connective Tissue Diseases (Connective Tissue Disease)
05/2005
1Myalgia
01/2002

Drug/Important Bio-Agent (IBA)

4AutoantibodiesIBA
12/2006 - 01/2002
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2008 - 01/2003
2Infliximab (Remicade)FDA Link
01/2008 - 01/2003
1Valproic Acid (Depakote)FDA LinkGeneric
02/2009
1Methotrexate (Mexate)FDA LinkGeneric
01/2008
1Pharmaceutical PreparationsIBA
01/2008
1Signal Recognition ParticleIBA
12/2006
1Creatine Kinase (Creatine Phosphokinase)IBA
12/2006
1Mi-2 antibodiesIBA
02/2006
1AntibodiesIBA
02/2006
1AntigensIBA
02/2006
1AutoantigensIBA
02/2006
1Histocompatibility Antigens Class IIBA
01/2004
1CytokinesIBA
01/2003
1His Transfer RNAIBA
01/2002
1Ligases (Synthetase)IBA
01/2002

Therapy/Procedure

1Therapeutics
01/2003